Abnormal findings on antenatal screening of mother. Abnormal biochemical finding on antenatal screening of mother
Conditions
Interventions
Intervention 1: Omega 3, 1000mg (one capsule), since 16th week pregnancy to termination (week 40). Intervention 2: No supplementation.
Treatment - Drugs
Prevention
Omega 3, 1000mg (one capsule), since 16th week pregnancy to termination (week 40)
Sponsors
Arak University of Medical Sciences and Health Services
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: singleton pregnancy, age between 18-40, any acute or chronic diseases, prenatal care before 16th gestational week Exclusion criteria: Irregular or no consumption of omega 3, discountinued prenatal care, smoking
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lipid peroxide. Timepoint: 38th week of pregnancy. Method of measurement: 5 cc of venous blood.;The ability of plasma to reduce the Ferric Ions to the Ferro. Timepoint: 38th week of pregnancy. Method of measurement: 5 cc of venous blood. | — |
Secondary
| Measure | Time frame |
|---|---|
| Thiol group. Timepoint: 38th week of pregnancy. Method of measurement: 5 cc of venous blood. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactKatayon Vakilian
Arak University of Medical Sciences and Health Services
Outcome results
None listed